Jana Wobst,Natalie Wossidlo,Marietta Truger et al.
Jana Wobst et al.
Development of lymphomatoid papulosis during brentuximab vedotin treatment: a paradoxical phenomenon [0.03%]
布雷特定素治疗期间淋巴样乳头状皮病的发展：一个悖论现象
Juan Torre-Castro,Raúl Cordoba,María Recuero et al.
Juan Torre-Castro et al.
Pericardial effusion and tamponade as a rare cardiac toxicity of covalent BTK inhibitors in CLL-a multi-modality study [0.03%]
共价BTK抑制剂在CLL罕见的心脏毒性-心包积液和心脏压塞的多模态研究
Liron Hofstetter,Shai Shimony,Adi Sherban et al.
Liron Hofstetter et al.
Bruton tyrosine kinase inhibitors (BTKi) have a unique cardiovascular toxicity profile. We investigated pericardial effusion and tamponade (PE/T) as a potential cardiac complication associated with BTKi therapy. We employed a multi-modal ap...
Targeting the FOXM1/BUB1B signaling network in multiple myeloma: mechanistic insights and therapeutic potential [0.03%]
靶向MM中的FOXM1 / BUB1B信号网络：机制见解和治疗潜力
Durdana Yasin,Neha Sami,Sarah Khalid et al.
Durdana Yasin et al.
Multiple myeloma (MM) is a plasma cell cancer characterized by genomic instability and drug resistance. The FOXM1 transcription factor and the BUB1B kinase are pivotal drivers of this malignancy. FOXM1 promotes cell cycle progression and is...
Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplantation [0.03%]
同种异体造血干细胞移植后卡氏肺孢子菌感染
Yumiko Toda,Shin-Ichiro Fujiwara,Seina Honda et al.
Yumiko Toda et al.
Pneumocystis jirovecii pneumonia (PJP) after autologous stem cell transplantation (ASCT) remains insufficiently characterized. We retrospectively analyzed 304 ASCT recipients (2005-2024) at a single center (B-cell lymphoma n = 138; plasma c...
Efficacy of CD19 CAR T-cell therapy for patients with B-cell acute lymphoblastic leukemia relapsed after allogeneic transplantation [0.03%]
CD19 CAR-T细胞疗法治疗allo-HSCT后复发的B淋巴细胞急性淋巴细胞白血病患者的疗效分析
Piyatida Chumnumsiriwath,Piyanuch Kongtim,Lavinia Lipan et al.
Piyatida Chumnumsiriwath et al.
Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia [0.03%]
IgM型多发性骨髓瘤及华氏巨球蛋白血症的临床病理特点和处理对策
Shayna Sarosiek,Jorge J Castillo,Zachary R Hunter et al.
Shayna Sarosiek et al.
Waldenström macroglobulinemia (WM) is the most common malignancy associated with an IgM paraprotein, but in rare cases, a clonal IgM may be the result of IgM multiple myeloma (IgM-MM). Although there are some overlapping features associate...
The spectrum of tonsillar involvement in chronic lymphocytic leukemia (CLL) [0.03%]
慢性淋巴细胞白血病（CLL）咽部受累的范围
Anthony Jeffrey,George Mason,Luke Coyle et al.
Anthony Jeffrey et al.
Tonsillar enlargement in chronic lymphocytic leukemia (CLL) either with or without symptoms has been rarely reported. We describe 22 cases of CLL with tonsillar involvement and demonstrate this is a CLL disease site that may be under-recogn...
Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024) [0.03%]
美国商业和 Medicare 保险索赔数据库中弥漫性大 B 细胞淋巴瘤（DLBCL）患者的治疗模式和特征：2017 年至 2024 年的回顾性分析
Tycel Phillips,Ziqi Zhou,Cynthia Gutierrez et al.
Tycel Phillips et al.
To understand the recent, evolving treatment landscape for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL), we retrospectively analyzed US claims data from MarketScan Commercial Claims and Encounters and Medicare databases and...
Epcoritamab for diffuse large B-cell lymphoma in a dialysis-dependent patient [0.03%]
血液透析依赖型弥漫性大B细胞淋巴瘤患者使用Epcoritamab治疗
Sophie Georgie Suke,Henry Miles Prince
Sophie Georgie Suke